| Compound | Description |
|---|
| gamma-aminobutyric acid | The most common inhibitory neurotransmitter in the central nervous system. |
| valproic acid | A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. |
| uridine diphosphate | A uracil nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety. |
| 2-propyl-4-pentenoic acid | putative toxic metabolite of valproic acid |
| 5-hydroxyvalproate | |
| uridine diphosphate glucuronic acid | A nucleoside diphosphate sugar which serves as a source of glucuronic acid for polysaccharide biosynthesis. It may also be epimerized to UDP iduronic acid, which donates iduronic acid to polysaccharides. In animals, UDP glucuronic acid is used for formation of many glucosiduronides with various aglycones. |
| 2-propyl-2,4-pentadienoic acid | toxic metabolite of valproic acid; RN given refers to cpd without isomeric designation |
| 4-hydroxyvalproate | RN given refers to compound with no isomeric designation |
| 2-n-propyl-3-oxopentanoic acid | structure given in first source |
| valproic acid glucuronide | major metabolite of valproic acid |
| propionyl-coenzyme a | RN given refers to parent cpd |